Burtonsville, MD, United States of America

Samuel K Martin

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignee: US Government as Represented by the Secretary of the Army. Active years: 1990-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel K Martin. Retrieved from https://idiyas.com/inventor/samuel-k-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 28.6

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 24(Granted Patents)


Location History:

  • Silver Spring, MD (US) (1990)
  • Nairobi, KE (2008 - 2011)
  • Burtonsville, MD (US) (2006 - 2014)

Company Filing History:


Years Active: 1990-2014

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Samuel K. Martin

Introduction

Samuel K. Martin is a notable inventor based in Burtonsville, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of kinetoplastid infections. With a total of 7 patents to his name, Martin's work has had a profound impact on clinical and veterinary practices.

Latest Patents

One of Martin's latest patents focuses on the use of artemisinins in the clinical and veterinary management of kinetoplastid infections. This invention relates to the treatment of these infections by administering a pharmaceutical composition containing an extract from a specific plant. It also includes isolated, semi-synthetic, and synthetic artemisinins that demonstrate improved efficacy in treating kinetoplastid infections. Additionally, the patent outlines a method of treating these infections with artelinic acid and artemisinins, where artelinic acid is administered orally.

Another significant patent involves a method for obtaining a cellular product from a cell or tissue using a protein-free medium. This patent discloses methods for diagnosing visceral, cutaneous, and canine leishmaniasis in subjects suspected of being infected with the parasitic protozoa. It includes antibody-capture enzyme-linked immunosorbent assays (ELISAs) for detecting antibodies to parasite soluble antigens, as well as antigen-capture ELISAs for detecting parasite soluble antigens in host samples. The methods and kits allow for photometric or visual detection and enable the visualization of amastigotes or promastigotes in a sample.

Career Highlights

Samuel K. Martin is currently associated with the US Government as represented by the Secretary of the Army. His work has been instrumental in advancing medical treatments and diagnostic methods, showcasing his dedication to improving health outcomes.

Collaborations

Throughout his career, Martin has collaborated with notable colleagues, including Wilbur K. Milhous and Bruno K. Kubata. These collaborations have further enriched his research and innovations in the field.

Conclusion

Samuel K. Martin's contributions to the field of medicine through his patents and collaborations highlight his commitment to innovation and improving healthcare. His work continues to influence the treatment of kinetoplastid infections and diagnostic methods, making a lasting impact in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…